Several investigations have supposed that tumor suppressor genes might be located on human chromosome 8. We used microcell-mediated transfer of chromosome 8 into MDA-MB-231 breast cancer cells and generated independent hybrids with strongly reduced tumorigenic potential. Loss of the transferred chromosome results in reappearance of the malignant phenotype. Expression analysis identified a set of 109 genes (CT8-ps) differentially expressed in microcell hybrids as compared to the tumorigenic MDA-MB-231 and rerevertant cells. Of these, 44.9% are differentially expressed in human breast tumors. The expression pattern of CT8-ps was associated with prognostic factors such as tumor size and grading as well as loss of heterozygosity at the short arm of chromosome 8. We identified CT8-ps networks suggesting that these genes act cooperatively to cause reversion of tumorigenicity in MDA-MB-231 cells. Our findings provide a conceptual basis and experimental system to identify and evaluate genes and gene networks involved in the development and/or progression of breast cancer.
Introduction
Breast Cancer (BC) is thought to result from the accumulation of a number of genetic alterations, including inactivation of tumor suppressors. Loss of heterozygosity (LOH) analysis and comparative genomic hybridization (CGH) indicate that allelic losses of human chromosomes 1p, 3p, 6q, 8p, 9p, 11p, 13q, 16q and 17p are detected frequently in more than 20-25% of primary BC, suggesting the presence of tumor suppressor genes (TSG) in these regions of the genome (Lerebours and Lidereau, 2002) . The regions of LOH in BC are usually large and complex and it is difficult to identify candidate genes relying on allelic loss alone. Furthermore, dissection of genetic events in LOH regions is complicated by factors such as tumor heterogeneity and contamination with nonmalignant material (Murakami, 2002) . It is therefore important to obtain functional evidence for a TSG before laborious positional cloning attempts are made.
Microcell-mediated chromosome transfer (MMCT) is an alternative approach to identify TSGs in sporadic cancers. Cancer cells showing deletions at the target chromosomal region are preferentially used as recipient, working on the assumption that both alleles of a TSG have been inactivated. The altered phenotype exhibited by MMCT hybrids, as compared to the parental cancer cells, allows conclusions regarding the location and the function of genes relevant for neoplastic development under physiological conditions (Kugoh et al., 2002) .
Several lines of evidence suggest that chromosome 8 harbors one or more TSGs in BC. Various laboratories, including ours, have reported up to 86% LOH in both familial and sporadic BC as well as in ductal carcinoma in situ (Seitz et al., 1997 (Seitz et al., , 2000 Suzuki et al., 1999) . LOH on chromosome 8p is also associated with higher grade and invasive behavior of tumors (Yaremko et al., 1996; Seitz et al., 2000) and has been proposed as a prognostic indicator to guide postoperative management of patients (Tsuneizumi et al., 2002) . Studying 305 breast tumors by CGH Rennstam et al. (2003) found that combined loss of 8p and gain of 8q, one of the most common coupled aberrations in BC, is correlated with high DNA nondiploidy, high histological grade, lymph node positivity and low survival rate.
Functional evidence for one or more TSGs on chromosome 8p stems from MMCT of chromosome 8 into rat prostate-and colorectal cancer cells, indicating the existence of a metastasis suppressor gene at 8p12-p21 and a TSG at 8p22-p23, respectively (Gustafson et al., 1996; Nihei et al., 2002) . The critical regions defined for these putative suppressor genes encompass the regions most commonly deleted in BC.
Few if any studies have linked functional changes to the presence or absence of chromosome 8 in breast tumor cells. Recently, Wilson et al. (2003) reported transfer of chromosome 8 into two BC cell lines and localized three chromosome 8p regions harboring putative in vitro growth suppressor genes. However, these authors did not provide evidence for suppression of tumorigenicity in vivo.
In the present study, we provide an experimental system to identify and evaluate genes and gene networks involved in BC genesis. For the first time we provide functional evidence for the presence of tumor suppressor(s) on chromosome 8(p) and show that the suppression of the tumorigenic phenotype of the BC cell line MDA-MB-231 is mediated by a specific set of genes (CT8-ps)/networks regulated by one or more genes on chromosome 8. It is of particular interest that the CT8-ps signature is also reflected in a panel of breast tumors and is correlated with worse patient prognosis.
Results

Homozygosity mapping of deletions (HOMOD) analysis of breast cancer cell lines
We analysed a panel of 11 breast cancer cell lines with 24 microsatellite (MS) markers for extended regions of hemizygosity (X5 adjacent markers). These are indicative for allelic loss in the unmatched tumor cells (Goldberg et al., 2000) . These markers were concentrated in the 8p12-p21 region previously determined to be frequently deleted in BC (Seitz et al., 2000) . We identified four cell lines (MDA-MB-231, CAMA-1, T-47D, showing deletions of the 8p12-p21 region, which are suitable as recipients of chromosome 8 by MMCT (data not shown).
Selection of MDA-MB-231 as recipient cells for MMCT
As demonstrated by HOMOD -analysis, the MDA-MB-231 cells were found to have a region of extended hemizygosity of about 10 Mb at chromosomal region 8p12-p21, encompassing the critical regions defined by LOH analysis (Figure 1a ). CGH analysis of these cells revealed loss of chromosomal region 8pter-8q21and gain of 8q21-qter (Figure 1b ). In addition, we compared the gene expression profiles of MDA-MB-231 cells with MCF-10A breast epithelial cells and found a high frequency (28.7%) of chromosome 8 genes differentially expressed (data not shown). This frequency of differentially expressed genes is significantly higher (Po0.0001) as compared to all 22 283 probe sets (ps) spotted on the U133A GeneChip, where only 20.3% of the genes were differentially expressed in MDA-MB-231 cells.
Restoration of human chromosome 8 in MDA-MB-231 breast cancer cells
To identify a functional role for chromosome 8 in breast cancer, we introduced an intact copy of chromosome 8 into the MDA-MB-231 cell line. Following transfer, eight microcell hybrid clones were isolated, expanded as distinct cell lines and characterized. First, the hybrid cells were screened for the presence of the neo R gene by PCR using specific primers and the presence of the transferred chromosome 8 using 19 informative MS markers. In all hybrid cells, the presence of the neo R gene was detected, thus confirming that the G418-resistant colonies arose as a result of microcell fusion (data not shown). MS analyses revealed that all hybrid clones carried the donor allele (Figure 1a and c). These data are consistent with the results of cytogenetic analyses. As shown by FISH-MD CT60/4 hybrid cells contain an entire chromosome 8 (donor chromosome), whereas in MDA-MB-231 cells only fragments of this chromosome were detected ( Figure 1d , Weimer et al., in preparation) . In addition, CGH analyses demonstrated amplification of chromosome 8 in the hybrid clones (CT60/4, CT60/6) as compared to the parental MDA-MB-231 cells (Figure 1e ). In parallel, hybrids (CT60/4, CT60/6) were screened with FISH to determine whether any mouse chromosomes had inadvertently been transferred along with the neo R -tagged chromosome 8. Both cell lines were found to be negative for the presence of contaminating mouse DNA.
Consequences of chromosome 8 transfer in MDA-MB-231 breast cancer cells
The eight microcell hybrids were first tested for differences in cell morphology. In general, the hybrid cells appeared flatter than the MDA-MB-231 parental cell line (data not shown). All microcell hybrids showed decreased anchorage-dependent growth. The doubling times for exponentially growing MDA-MB-231 cells were 28.9 h, whereas the doubling times of the eight microcell hybrids varied between 33.4 h (CT60/4) and 44.6 h (CT60/8) (medium 37.7 h) ( Figure 2a) . Next, we determined the effect of transferred chromosome 8 on breast cancer cell invasion in vitro. As shown in Figure 2b , hybrid CT60/4 cells showed a clear reduction of invasive cells (>97%) compared with the parental MDA-MB-231. We characterized two microcell hybrids, CT60/4 and CT60/6, in vivo to determine their tumorigenic potential. The CT60/4 cells ( Figure 2c ) did not form tumors during a 3-month observation period and CT60/6 cells exhibited a clear reduction in the ability to form tumors in nude mice in comparison to the parental cell line. Tumors formed after CT60/6 injection appeared following a delayed latency period of at least 3 weeks and showed a significant reduction of tumor volume when compared to the parental cells.
Next, we analysed the effect of introduction of human chromosome 8 into MDA-MB-231 cells on cell-cycle progression using FACS. The cell-cycle profile did not Re-expression of the tumorigenic phenotype in microcell hybrid clones
To confirm whether the introduction of the chromosome 8 was the cause for the observed suppression of tumorigenicity, the microcell hybrids CT60/4 and CT60/6 were cultivated for 8 weeks in G418-free medium. A total of 27 subclones were isolated and analysed for the presence of the neo R gene. In all, 22 subclones lost the neo marker. One of these clones (CT60/4-12) was examined in more detail. MS analyses (Figure 1a and c) and FISH-MD showed loss of the donor allele in CT60/4-12 cells. In addition, these cells show a CGH profile comparable with MDA-MB-231 cells and indicative for loss of chromosome 8 material.
To address the question, whether the microcell hybrid cells that lost the donor chromosome became functionally revertants, anchorage-dependent growth, invasiveness through the matrigel-reconstituted basement membrane and tumorigenicity in nude mice were tested. CT60/4-12 cells showed a reduced doubling time (22.9 h) in comparison to the microcell hybrids thus comparable to the parental cells (Figure 2a) . A significant increase of the invasive potential in CT60/4-12 cells was demonstrated when compared with the corresponding hybrid CT60/4 cells (Figure 2b ). Unlike CT60/4 and comparable to the parental MDA-MB-231 cells, the clone CT60/4-12 formed tumors in nude mice (Figure 2c ). In addition, CT60/4-12 cells were morphologically similar to the parental MDA-MB-231 cells.
Microarray hybridization and search for candidate genes on chromosome 8
As a strategy to identify transcriptional targets likely to contribute to the suppression of the tumorigenic phenotype in CT60/4 cells, we used oligonucleotide A total of 134 ps (107 genes) fulfill the criteria for differential expression, defined in the Materials and methods section. These genes are listed in the supplement. A total of 95 ps (75 genes) were upregulated and 39 ps (33 genes) were downregulated in CT60/4 cells as compared to the tumorigenic MDA-MB-231 and CT60/ 4-12 cells, respectively. It is noteworthy that 43.3% of the identified ps are also differentially expressed in MDA-MB-231 cells compared to the MCF-10A breast epithelial cell line (see Supplement table) .
Of the 107 differentially expressed genes, five genes mapped to chromosome 8. Four genes were mapped outside the 8p12-p21 target region, including INDO, located at 8p11-p12, FLJ20533, CCNE2 and NOV, which mapped to 8q13.3-q24.1. Only one gene, clusterin (CLU), was located within the target region. This region is flanked by the markers D8S1752 and D8S259. According to the Entrez Map Viewer (http:// www.ncbi.nlm.nih.gov/mapview/map_search.cgi), a total of 131 genes has been mapped within this region, 57 of them are arrayed on the U133A GeneChip. Of these 57 genes, 32 genes were scored as present, 25 genes as being absent on the GeneChip. We used reverse transcription-polymerase chain reaction (RT-PCR) analysis to test eight of these 25 genes including ADAM28, NEFL, GNRH1, PTK2B, EPHX2, CSR1, PNOC and EXTL3 and identified two additional genes, the exostoses (multiple-) like 3 (EXTL3) gene and ADAM28, a disintegrin and metalloproteinase domain gene, overexpressed in CT60/4 as compared to MDA-MB-231 and CT60/4-12 cells, respectively ( Figure 3 ).
Functional profiling of differentially expressed genes
We used Onto-Express (http://vortex.cs.wayne.edu:8080) to correlate expression data with functional profiles (Khatri et al., 2002) . The selected 109 genes are involved in a diverse spectrum of cellular functions with the Chromosome transfer and gene expression analysis S Seitz et al majority of them participating in immune response, cell proliferation, signal transduction, cell-cell signaling, inflammatory response, neurogenesis, oncogenesis and cell adhesion. A literature search using LocusLink (http:// www.ncbi.nlm.nih.gov/LocusLink/list.cgi) revealed that 20 and seven of the 109 genes in our set have previously been associated with cancer or breast cancer, respectively.
The differential expression of multiple genes from different chromosomes in CT60/4 microcell hybrids raises the question of their functional significance. To determine the biological relationship between the 109 differentially expressed genes and to identify coexpressed groups of genes associated in the literature, we used PubGene web tools (http://www.pubgene.org/ tools/Network/Subset.cgi) (Jenssen et al., 2001) . We identified 40 genes which co-occurred in the literature with at least one other gene of the CT8-ps (Figure 4 ).
The numbers of literature co-occurrences between two genes varied from 1 to 358. The 40 genes cluster into five networks (a-e). In cluster a, 31 genes including four on chromosome 8 (NOV, CLU, ADAM28, INDO) are connected. The other four clusters consist of two or three genes.
In a second step, we analysed the gene expression data in the context of literature associations (http:// www.pubgene.org/tools/ExpressionData/Analysis.cgi). The expression data are superimposed on the literature network to compute an expression score for each gene in the CT8-ps. Under the criteria of upregulation, the top-scoring cluster included a network of interferoninduced proteins with tetratricopeptide repeats (IFITs) (Figure 4b ). When we analysed our gene-set under the criteria of downregulation in CT60/4 vs MDA-MB-231 cells, the highest ranking cluster consisted of six genes, including QPCT, CSF3, IL11, IL1A, CXCR4 and TLR4 (Figure 4a ). Blue colored genes reflect genes downregulated and green colored are genes upregulated in revertant vs MDA-MB-231/rerevertant cells. The subnetwork containing IFIT1, IFIT2 and IFIT4 was ranked as the most upregulated, whereas the six-gene network containing QPCT, CSF3, IL11, IL1A, CXCR4 and TLR4 was ranked as the most downregulated one. Both subnetworks are marked.
The numbers next to the links correspond to the number of literature co-occurrences between the linked genes. Only genes which cooccurred more than once in the literature are numbered To gain insight into the prognostic relevance of the CT8 gene set, the expression data were correlated to established prognostic factors such as tumor size, lymph node status, histological grade and patient age at the time of diagnosis. Differential expression of all CT8-ps was significantly correlated to higher grading (P ¼ 0.019) and higher tumor size (P ¼ 0.001) ( Table 1 ). In addition, we found a significant correlation between the CT8 expression profile and LOH at 8p (P ¼ 0.002) ( Table 1) . Of the 17 tumors tested, nine showed LOH at the 8p target region, eight tumors did not. The highest percentage of differentially expressed genes (52.5%) was found in tumors with LOH at 8p and high grading (P ¼ 0.002) compared to tumors with LOH and lower grading or tumors without 8pLOH (data not shown).
To further evaluate the clinical relevance of the CT8-ps, we analysed the correlation between the expression of CT8 single genes and clinico-histopathological parameters, the age at diagnosis and the 8p LOH status. As shown in Table 1 , we identified 13 genes (15 ps) whose expression pattern was significantly correlated with tumor size, age at diagnosis and 8p LOH. Three of these genes are located on chromosome 8: CLU and ADAM 28 on 8p, NOV on 8q.
Discussion
This study provides the first functional evidence that one or more tumor suppressor's contributing to BC tumorigenesis exist on chromosome 8. The microcell hybrids generated are characterized by altered morphology, reduced anchorage-dependent growth, invasive potential and substantially reduced tumorigenic capability in nude mice. Loss of chromosome 8 in hybrid cells restored the original tumorigenic potential of MDA-MB-231 cells, implying that suppression of tumorigenicity was, in fact, caused by introduction and retention of chromosome 8.
In order to identify genes or groups of genes which contribute to the suppression of the tumorigenic There were a total of 109 genes that met our criteria for differential expression. These genes represent a variety of functional groups including cell proliferation, signal transduction, cell-cell signaling and cell adhesion. In addition, there are several genes with more specialized roles, reflecting, as an example, stromal and inflammatory components of the tumor tissues. One of the 109 differentially expressed genes, CLU, and additional two genes, EXTL3 and ADAM28, both identified by RT-PCR analysis, were located within the 8p12-p21 target region. All three genes have been suggested to be involved in tumorigenesis. CLU is implicated in many biological processes, such as cell adhesion, lipid transport, reproduction and apoptosis (Jones and Jomary, 2002; Trougakos and Gonos, 2002) and has been reported to be overexpressed in some types of cancer (Steinberg et al., 1997; Redondo et al., 2000) , but downregulated in others (Behrens et al., 2001; Saffer et al., 2002; Scaltriti et al., 2004) . This may reflect differences in the relative levels of the various isoforms (Pucci et al., 2004) . Members of the ADAM protein family have been implicated in cell-cell and cell-matrix interactions (Primakoff and Myles, 2000) . EXTL3 is a member of the exostosis (EXT) gene family, which has been tightly associated with glycosyltransferase activities required for the biosynthesis of heparin sulfate (Kim et al., 2001) . For two members of the EXT-family, EXT1 and EXT2, a TSG function has been postulated. This was proved by frequent LOH at both gene loci in various human cancers and intragenic mutations in sporadic chondrosarcomas (Hogue et al., 1996) . The sequence and functional similarities between the EXTand the EXTL3 genes suggest also a TSG function for the latter.
Four additional genes that met the threshold criteria for differential gene expression mapped to chromosome 8. One of these genes, INDO, a g interferon-induced gene with antiproliferative effect, was mapped near the 8p12-p21 target region (Logan et al., 2002) . The other three genes mapped to 8q13.3-q24.3 including NOV, a member of the CCN family of proteins, FLJ20533 and cyclin E2 that are involved in cell cycle regulation and control of cell proliferation (Gudas et al., 1999; Strezoska et al., 2002; Borg et al., 2003) . Interestingly, two of the genes (NOV, CCNE2) have previously been found to be aberrantly expressed in human cancers, including BC (Gudas et al., 1999; Payton et al., 2002) .
All chromosome 8 candidate genes were overexpressed in the CT60/4 hybrids as compared to the tumorigenic MDA-MB-231 and CT60/4-12 cells. This is consistent with a tumor suppressor activity.
For the majority of the 109 differentially expressed genes in CT60/4 cells, the precise function as well as the underlying biological relationships between these genes in the course of BC development remain unknown or unclear. We used PubGene web tools to identify groups of genes that had co-occurred in the literature and whose expression pattern may shed light on signaling pathways and critical effectors of these genes (Jenssen et al., 2001) . Recently, it has been demonstrated that gene pairs with network neighborhoods occurring more frequently together in article abstracts can be functionally related. These genes more frequently encode proteins that interact physically than do genes with dissimilar neighborhoods (Schlitt et al., 2003) . We found 40 genes co-occurring at least once in article abstracts with one of the 109 genes identified. They cluster into five networks (a-e). Some of them contain only two genes. However, network A contains a large number of genes. In particular, gene pairs CSF3-IL1A, IL1A-IL11, CSF3-IL11, IL1A-MMP1 and MMP1-TIMP3 in network A co-occur 358, 120, 91, 46 and 37 times, respectively, suggesting a functional relationship between them. This is strengthened by the data presented here as well as by data from elsewhere in the literature. In addition, we identified two top-scoring subnetworks that were ranked according to their content of up-or downregulated genes. Under the criteria of upregulation, the top-scoring gene cluster consists of a network of interferon-induced proteins with tetratricopeptide repeat motifs (IFITs). Two members of the IFIT gene family, IFIT1 and IFIT4, have been described as predictors of BC outcome (Huang et al., 2003) . Furthermore, IFIT genes have been mapped to chromosome 10q23-q26, a genome region frequently deleted in different types of cancer, including BC (Singh et al., 1998) . Interferon-induced genes are also involved in network c, consisting of members of oligoadenylate synthases (OAS1 and OAS2) and are also found in a gene cluster within network a (MX1, ISG20). These findings are intriguing in view of the role of interferons as mediators of the antitumor response.
By analysing our gene-set under the criteria of downregulation, the highest ranking cluster consisted of six genes (QPCT, CSF3, IL11, IL1A, CXCR4 and TLR4), all included in network a. In a recent study, Kang et al. (2003) investigated the molecular basis for osteolytic bone metastasis by selecting MDA-MB-231 cell subpopulations with elevated metastatic activity and functionally validated genes overexpressed in these cells. They identified four genes (CXCR4, IL11, CTGF and MMP1) that are highly overexpressed in bone metastases. These genes act cooperatively to cause metastasis and are already overexpressed in the parental MDA-MB-231 cells. We found that three of the metastasisassociated genes (CXCR4, IL11 and MMP1) are downregulated in CT60/4 as compared to the MDA-MB-231 and CT60/4-12 cells. These data imply a coordinate down-regulation of these genes by genes or regulator elements, which remained as yet unidentified. It is also of interest that Nihei et al. (2002) provided functional evidence for a metastasis suppressor gene for rat prostate cancer within the human chromosome region 8p21-p12. In this report, we have not assessed the consequences of chromosome 8 MMCT regarding suppression of the metastatic ability of MDA-MB-231 cells in athymic mice. However, based on our findings, we cannot exclude that the genes responsible for metastatic suppression identified by Kang et al. (2003) were regulated by genes located on chromosome 8 and are involved in tumor suppression.
Remarkably, by searching recent publications and databases, we found that expression of 44 of the CT8 genes (40.4%) have been suggested or proved to be correlated with cancer, BC or predictors of BC and/or metastasis outcome (van't Veer et al., 2002; Huang et al., 2003; Kang et al., 2003 ; http://www.ncbi.nlm.nih.gov/ LocusLink/).
To explore the relevance of the MMCT-derived CT8-ps in breast cancer tissues, we ascertained the expression profile of 17 breast carcinomas. We found 44.9% of the CT8-ps as differentially expressed in the tumor samples, demonstrating a significantly higher percentage as compared to all ps spotted on the U133A GeneChip. A similar high percentage of differentially expressed ps as for the CT8-ps was found with 46 ps of a 70 gene predictor set recently reported by van't Veer et al. (2002) . In addition, the CT8-ps expression pattern was significantly correlated with prognostic factors such as higher grading and larger tumor size. Taken together, these data strongly suggest the relevance of the CT8-ps for breast cancer tumorigenesis.
The clinical relevance of the CT8-ps was further strengthened by analysing the correlation between the expression of single genes within the CT8-ps and clinicohistopathological parameters, age of the patients at diagnosis and 8pLOH status of the tumors. We detected 13 genes whose expression pattern correlated with tumor size (IFI44, CXCL10, FLJ20073, CLU, IFIT1 FKBP11, MX1), grading (LIM, ADAM28, NOV), age at diagnosis (TIMP3) and 8pLOH (FLJ20637, PSPHL, NOV, TIMP3). CLU and ADAM28 are located on 8p, NOV on 8q.
In conclusion, we have shown that introduction of chromosome 8 into MDA-MB-231 cells results in an altered phenotype with strongly reduced tumorigenic potential and is accompanied by characteristic changes in gene expression. These changes were also observed in a panel of human breast tumors. Both, the complete set of differentially expressed genes (CT8-ps) and various genes of this gene set can be correlated with established prognostic factors and LOH at the short arm of chromosome 8. The data presented here and by other authors suggest that differentially expressed genes within the CT8-ps are significantly associated with tumor suppression. A detailed analysis of these genes and their interactions will help to determine the extent of their involvement in breast cancer development. To confirm their identity, the cell lines were screened with the microsatellite (MS) markers D16S539, D5S818 and D7S820 and the resulting fingerprints compared with the corresponding entries in the ATCC STR human cell line database (http://www.atcc.org/Cultures/str.cfm) as described in Seitz et al. (2003) .
Materials and methods
Cell lines
DNA and RNA extraction
DNA was extracted by standard methods, involving proteinase K digestion, phenol/chloroform extraction and ethanol precipitation (Sambrook et al., 1989) .
Total RNA was isolated using TRIzol Reagent (Life Technologies, Gaithersburg, MD, USA) according to the manufacturer's instructions. All tumor specimens analysed contained more than 80% tumor cells. RNAs of the normal breast samples were pooled.
HOMOD on chromosome 8 in breast cancer cell lines
To fine-map the area of interest, we narrowed the region of deletion by HOMOD in 11 breast cancer cell lines. A total of 28 MS markers covering the whole of chromosome 8 were selected from the Human Genome database (http:// www.gdb.org/). Their relative order was established using the NCBI database (http://www.ncbi.nlm.nih.gov/) (Figure 1 ). PCR primers were purchased from BioTez (Berlin, Germany). PCR reactions were carried out in a 10 ml reaction containing 40 ng of genomic DNA, Taq PCR Master Mix (QIAGEN, Hilden, Germany) (1.5 U Taq DNA Polymerase, 1 Â PCR buffer, 200 mM of each dNTP) and 2.5 pmol of each primer. One member of each primer set was tagged with a fluorescent label. Initial denaturation was performed at 951C for 5 min, followed by 35 cycles of 30 s at 941C, 30 s at the optimal annealing temperature and 1 min at 721C, with a final extension at 721C for 10 min. The fluorescent PCR products were mixed with an internal standard size marker and analysed on denaturing 6% polyacrylamide gels using an ABI 377 DNA sequencer.
LOH mapping in breast tumors
LOH analysis of 17 tumors and corresponding nontumorous tissues was performed using the MS markers NEFL and D8S1989 (http://www.gdb.org/) as described above. If the patient was not informative for the two markers, a dinucleotide repeat near NEFL was analysed using the primers 5 0 -6-FAM-CAGAACCATGGACAGAGT-3 0 and 5 0 -TCAGGCA ATTACAGGAGG-3 0 . LOH was ascertained by comparing nontumorous and tumor tissue allele peak sizes. Intensity or signal ratio differences of 35% or more were considered sufficient for LOH assignment.
MMCT MMCT was performed as described by Theile et al. (1994) . Briefly, donor A9neo8 cells were treated with 0.05 mg/ml colcemid in DMEM supplemented with 20% FBS for 48 h at 371C. The flasks were filled with medium containing 10 mg/ml cytocholasin B and centrifuged in a Sorvall fixed-angle rotor GSA at 8000 r.p.m. for 60 min at 351C. Microcell pellets were resuspended and filtered through 8, 5 and 3 mm polycarbonate filters. Purified microcells were attached to subconfluent recipient MDA-MB-231 cells with prewarmed serum-free medium containing 50 mg/ml phytohemagglutinin P (Sigma) and then fused to recipient cells with 50% polyethylene glycol (MW 1500) (Roche Diagnostics GmbH, Mannheim, Germany) for 2 min. After 2 days the cells were split, plated at a density of 5 Â 10 5 cells per 60 mm dish and cultured for 2-3 weeks to select for cells that contained a neo R -tagged human chromosome 8. Colonies were isolated using cloning cylinders, transferred to 48-well plates and expanded for further analysis. From the chromosome transfer experiments, eight subclones were obtained.
Analysis of microcell hybrids
Neo-specific PCR To confirm the presence of the introduced chromosome 8 in the hybrid cells, we first performed PCR to detect the neo R gene. For PCR, we used the same conditions as described but omitted the fluorescence labeling. The sequence of the neo R primer used are: 5 0 -ACTGGGCACAACAGA CAATC-3 0 and 5 0 -GCCATTTTCCACCATGATAT-3 0 . The PCR products (536 bp) were separated by acrylamide gel electrophoresis and visualized by staining with ethidium bromide.
Allelotyping of chromosome 8 in microcell hybrids Eight hybrid cells were tested for successful transfer of human chromosome 8 using 19 informative MS markers as described above (Figure 1 ).
FISH and FISH MD
The paints for a multiplex FISH were generated by microdissection. All paints (300-500 ng each) were solved with 20 mg Cot-1 in a hybridization mix (2 Â SSC, 50% formamide, 10% dextransulphate, 1% Tween 20, pH 7.0). The following paints were hybridized together: WCP8 labeled with Biotin-16-dUTP, 8p labeled with Spectrum-green-dUTP, 8q12 labeled with Texas-Red-dUTP and 8q21-qter labeled with Diethylaminocoumarin-5-dUTP (DEAC). In all, 10 ml of each paint were denatured for 5 min at 751C and prehybridized for 30 min at 371C. The further procedure of hybridization and detection followed standard protocols. For microdissection of fluorescence labeled tumor chromosomes (FISH-MD), the hybridization was performed as described by Weimer et al. (1999 Weimer et al. ( , 2000 and the generated paints were hybridized on unobtrusive lymphocyte metaphases as described above. An epifluorescense microscope (Axioplan 2, Zeiss, Go¨ttingen, Germany) and ISISsoftware Version 3 (MetaSystems, Altlussheim, Germany) were used for Image analysis.
Hybridization of genomic mouse DNA
We used a mouse genomic paint generated by microdissection of 10 mouse lymphocyte nuclei. This probe has been amplified by DOP-PCR and labeled by Diethylaminocoumarin-5-dUTP (NEN Life Science) in a further DOP-PCR step as described by Weimer et al. (2000) .
CGH
CGH was carried out according to Arnold et al. (1996) with minor modifications. Briefly, 2 mg of genomic DNA was labeled in a standard nick-labeling procedure with biotin-16-dUTP and digoxigenin-11-dUTP (Roche Diagnostics GmbH) for tumor and reference DNA, respectively, in a standard nicklabeling procedure. For hybridization, 250-400 ng of tumor and reference DNA were coprecipitated in the presence of 10-50 mg Cot-1 DNA. The probes were hybridized onto normal male metaphase target slides (Vysis distributor: Abbott, Wiesbaden, Germany) for 2-3 days in a moist chamber at 371C. Posthybridization washes were performed without formamide as follows: 5 min at 2 Â SSC at room temperature, 5 min at 721C and a final 5 min wash at room temperature. After detection with streptavidin-fluorescein isothiocyanate and anti-digoxigenin-rhodamine antibody (both Roche Diagnostics GmbH), the slides were counterstained with 0.1 mg/ml DAPI in antifade. CGH hybridization was analysed using a fluorescence microscope (Axioplan 2) connected to a digital imaging system and evaluated with the ISIS-3 software (MetaSystems).
Anchorage-dependent growth
Growth rate was determined in duplicate in parental and hybrid cells by plating 2.5 Â 10 4. cells into 60 mm culture dishes containing medium supplemented with 5% FBS. Cells were counted every 24 h over a 5-day period and starting from day 3 after plating using the cell counter and analysis system CASY s 1/TTC (Scha¨rfe System GmbH, Reutlingen, Germany).
Anchorage-independent growth
To assay colony formation in soft agar, 2.5 Â 10 4. cells in 0.3% agarose medium (3 ml) containing 10% FBS were layered onto 0.6% agar medium (4 ml) containing 10% FBS in a 60 mm culture dish. Cells were incubated at 371C for 3 weeks. In our hands and in contrast to the results, published by Zhang et al. (1991) , the MDA-MB-231 cells did not form colonies in soft agar.
In vitro invasion assay
Cell invasion was assayed in a 24-well BioCoat Matrigel Invasion Chamber with a pore size of 8 mm (BD Biosciences) according to the manufacturer's protocol. Briefly, 2.5 Â 10 4 cells were plated in the top chamber. The bottom chamber contained 10% FBS as a chemoattractant. After 22 h incubation, cells that have migrated through the membrane were fixed with methanol and stained with 1% Toluidine blue. Assays were performed in duplicate.
Tumorigenicity test
Suspensions of 1 Â 10 6 cells in 100 ml serum-free culture medium were injected subcutaneously into the left inguinal region of 5-to 7-week-old female immune-deficient nude mice (NMRI/nu-nu). Three to five mice were injected per group. Tumor growth was monitored once a week over a 12-week period.
Fluorescence-activated cell sorter (FACS) analysis
Cells were harvested by trypsin digestion, collected by centrifugation at 300 g, 41C for 5 min, washed with PBS at 41C, and fixed in PBS/1% formaldehyde on ice for 30 min. After fixation, the cells were incubated with ethanol/ PBS (2 : 1) for 15 min, pelleted, and re-suspended in PBS containing 40 mg/ml RNase A. After incubation for 30 min at 371C, the cells were pelleted again, resuspended in PBS containing 50 mg/ml propidium iodide and subjected to FACS. Data were collected and analysed using a FACScan (Becton Dickinson, Heidelberg, Germany) equipped with the CELLQuest software.
Preparation of cRNA and GeneChip hybridization
Biotin-labeled cRNA was synthesized from 5 mg of total RNA isolated from each cell line at two distinct passage numbers. Double-stranded cDNA was synthesized using the cDNA Synthesis System (Roche diagnostics GmbH) and SuperScripttIIRNaseH À Reverse Transcriptase (Invitrogen, Groningen, The Netherlands). In vitro transcription was carried out in the presence of biotinylated UTP and CTP (Perkin Elmer, Boston, MA, USA) by using MEGAscript T7 in vitro Transcription Kit (Ambion, Cambridgeshire, UK). In the case of tissue samples, cRNA was amplified from 1 to 2 mg of total RNA using the Small Sample Labeling Protokoll vII (Affymetrix, Santa Clara, CA, USA) with minor modifications. Biotin-labeled cRNA was purified using RNeasy spin column (QIAGEN), its quality assessed by gel electrophoresis, and fragmented. Hybridization and scanning of the oligonucleotide microarray ((Human Genome U133A Array, 22 283 probe sets); (Affymetrix)) were performed according to the manufacturer's protocols. Chip data sets were analysed with the Affymetrix GeneChip analysis software (Microarray Suite Version 5.0) and exported to Microsoft EXCEL. The criteria we called a gene 'differentially expressed' are as follows: a difference call of 'increase' or 'decrease', a log ratio of X1.0 or pÀ1.0 (fold difference of X2.0 or pÀ2.0) and an absolute call of 'present' in either the baseline file or the experimental file or both.
Semiquantitative RT-PCR analysis
In total, 800 ng RNA was subjected to random-primed reverse transcription in a 40 ml PCR reaction using SuperScripttIIRNaseH À Reverse Transcriptase (Invitrogen). PCR reactions were carried out in a 22 ml reaction containing 1-3 ml of the RT-PCR reaction, Taq PCR Master Mix (QIAGEN) and 5 pmol of each primer. Primer sequences are available upon request. The PCR products were separated by acrylamide gel electrophoresis and assessed by quantitative densitometry of ethidium bromide-stained bands with the use of Gel Doc 2000 system and the Quantity One 4.01 software (Biorad, Munich, Germany). b-Microglobulin (B2M), GAPDH and PBGD were used to confirm cDNA integrity and normalization of cDNA yields. All reactions were repeated at least twice.
Statistical analyses
Statistical analysis was carried out using the SPSS package release 11.5. Gene expression was investigated for associations with tumor size, node-status, grading, age at diagnosis and LOH at 8p21 using the w 2 or Fisher's exact test. Differences in the frequencies of differentially expressed genes among gene sets were analysed using w 2 test. For all statistical tests, a significance level of 0.05 (5%) was used.
Detection of biological relationships between differentially expressed genes
Two PubGene Expression Analysis tools, Subset Network (http://www.pubgene.org/tools/Network/Subset.cgi) and the Expression Data Analysis tool (http://www.pubgene.org/tools/ ExpressionData/Analysis.cgi) were used to search for literature gene-networks in our set of differentially expressed genes. The following parameter settings were used: 'Score-depth': 3, 'Size of score neighborhood': 25, 'Score criteria': up-or downregulation, 'Calculation scheme': by gene association.
